Nonclassical HEDGEHOG-GLI signaling and its clinical implications

International Journal of Cancer

Volumn 135, Issue 1, 2014, Pages 1-6

  Shevde, Lalita A ^a   Samant, Rajeev S ^a  

^a University of Alabama at Birmingham   (United States)

Author keywords

cancer; GLI; Hedgehog pathway; microevironment; noncanonical; nonclassical

Indexed keywords

CANCER; GLI; HEDGEHOG PATHWAY; MICROEVIRONMENT; NONCANONICAL; NONCLASSICAL;

HEDGEHOG PROTEINS; HUMANS; LIGANDS; MOLECULAR TARGETED THERAPY; NEOPLASMS; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TUMOR MICROENVIRONMENT;

EID: 84899437452     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.28424     Document Type: Review

References (64)

1. Bailey JM, Singh PK, Hollingsworth MA,. Cancer metastasis facilitated by developmental pathways: sonic hedgehog, Notch, and bone morphogenic proteins. J Cell Biochem 2007; 102: 829-39.
2. Scales SJ, de Sauvage FJ,. Mechanisms of Hedgehog pathway activation in cancer and implications for therapy. Trends Pharmacol Sci 2009; 30: 303-12.
3. Osterlund T, Kogerman P,. Hedgehog signalling: how to get from Smo to Ci and Gli. Trends Cell Biol 2006; 16: 176-80.
4. Ruiz i Altaba A,. Hedgehog signaling and the Gli code in stem cells, cancer, and metastases. Sci Signal 2011; 4: pt9.
5. Robbins DJ, Fei DL, Riobo NA,. The Hedgehog signal transduction network. Sci Signal 2012; 5: re6.
6. Theunissen JW, de Sauvage FJ,. Paracrine Hedgehog signaling in cancer. Cancer Res 2009; 69: 6007-10.
7. Yang ZJ, Ellis T, Markant SL, et al. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 2008; 14: 135-45.
8. Raffel C, Jenkins RB, Frederick L, et al. Sporadic medulloblastomas contain PTCH mutations. Cancer Res 1997; 57: 842-5.
9. Xie J, Murone M, Luoh SM, et al. Activating Smoothened mutations in sporadic basal-cell carcinoma. Nature 1998; 391: 90-2.
10. Reifenberger J, Wolter M, Weber RG, et al. Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res 1998; 58: 1798-803.
11. Lee Y, Kawagoe R, Sasai K, et al. Loss of suppressor-of-fused function promotes tumorigenesis. Oncogene 2007; 26: 6442-7.
12. Bailey JM, Swanson BJ, Hamada T, et al. Sonic hedgehog promotes desmoplasia in pancreatic cancer. Clin Cancer Res 2008; 14: 5995-6004.
13. Bailey JM, Mohr AM, Hollingsworth MA,. Sonic hedgehog paracrine signaling regulates metastasis and lymphangiogenesis in pancreatic cancer. Oncogene 2009; 28: 3513-25.
14. Chen W, Tang T, Eastham-Anderson J, et al. Canonical hedgehog signaling augments tumor angiogenesis by induction of VEGF-A in stromal perivascular cells. Proc Natl Acad Sci U S A 2011; 108: 9589-94.
15. Beauchamp E, Bulut G, Abaan O, et al. GLI1 is a direct transcriptional target of EWS-FLI1 oncoprotein. J Biol Chem 2009; 284: 9074-82.
16. Morton JP, Mongeau ME, Klimstra DS, et al. Sonic hedgehog acts at multiple stages during pancreatic tumorigenesis. Proc Natl Acad Sci U S A 2007; 104: 5103-8.
17. Wang Y, Ding Q, Yen CJ, et al. The crosstalk of mTOR/S6K1 and Hedgehog pathways. Cancer cell 2012; 21: 374-87.
18. Keysar SB, Le PN, Anderson RT, et al. Hedgehog signaling alters reliance on EGF receptor signaling and mediates anti-EGFR therapeutic resistance in head and neck cancer. Cancer Res 2013; 73: 3381-92.
19. O'Toole SA, Machalek DA, Shearer RF, et al. Hedgehog overexpression is associated with stromal interactions and predicts for poor outcome in breast cancer. Cancer Res 2011; 71: 4002-14.
20. Mukherjee S, Frolova N, Sadlonova A, et al. Hedgehog signaling and response to cyclopamine differ in epithelial and stromal cells in benign breast and breast cancer. Cancer Biol Ther 2006; 5: 674-83.
21. Kubo M, Nakamura M, Tasaki A, et al. Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res 2004; 64: 6071-4.
22. Harris LG, Pannell LK, Singh S, et al. Increased vascularity and spontaneous metastasis of breast cancer by Hedgehog signaling mediated upregulation of CYR61. Oncogene 2012; 31: 3370-80.
23. Steg AD, Katre AA, Bevis KS, et al. Smoothened antagonists reverse taxane resistance in ovarian cancer. Mol Cancer Ther 2012; 11: 1587-97.
24. Steg AD, Bevis KS, Katre AA, et al. Stem cell pathways contribute to clinical chemoresistance in ovarian cancer. Clin Cancer Res 2012; 18: 869-81.
25. Ray A, Meng E, Reed E, et al. Hedgehog signaling pathway regulates the growth of ovarian cancer spheroid forming cells. Int J Oncol 2011; 39: 797-804.
26. Ciucci A, De Stefano I, Vellone VG, et al. Expression of the glioma-associated oncogene homolog 1 (gli1) in advanced serous ovarian cancer is associated with unfavorable overall survival. PloS one 2013; 8: e60145.
27. Xie J,. Hedgehog signaling in prostate cancer. Future Oncol 2005; 1: 331-8.
28. Sanchez P, Hernandez AM, Stecca B, et al. Inhibition of prostate cancer proliferation by interference with SONIC HEDGEHOG-GLI1 signaling. Proc Natl Acad Sci U S A 2004; 101: 12561-6.
29. Sanchez P, Clement V, Ruiz i Altaba A. Therapeutic targeting of the Hedgehog-GLI pathway in prostate cancer. Cancer Res 2005; 65: 2990-2.
30. Karhadkar SS, Bova GS, Abdallah N, et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004; 431: 707-12.
31. Li X, Ma Q, Xu Q, et al. SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial-mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway. Cancer Lett 2012; 322: 169-76.
32. Eberl M, Klingler S, Mangelberger D, et al. Hedgehog-EGFR cooperation response genes determine the oncogenic phenotype of basal cell carcinoma and tumour-initiating pancreatic cancer cells. EMBO Mol Med 2012; 4: 218-33.
33. Wang ZC, Gao J, Zi SM, et al. Aberrant expression of sonic hedgehog pathway in colorectal adenocarcinoma and melanosis coli. J Dig Dis 2013; 14: 417-24.
34. Qualtrough D, Buda A, Gaffield W, et al. Hedgehog signalling in colorectal tumour cells: induction of apoptosis with cyclopamine treatment. Int J Cancer 2004; 110: 831-7.
35. Berlin J, Bendell JC, Hart LL, et al. A randomized phase II trial of vismodegib versus placebo with FOLFOX or FOLFIRI and bevacizumab in patients with previously untreated metastatic colorectal cancer. Clin Cancer Res 2013; 19: 258-67.
36. Yoon JW, Gallant M, Lamm ML, et al. Noncanonical regulation of the Hedgehog mediator GLI1 by c-MYC in Burkitt Lymphoma. Mol Cancer Res 2013; 11: 604-15.
37. Singh RR, Kim JE, Davuluri Y, et al. Hedgehog signaling pathway is activated in diffuse large B-cell lymphoma and contributes to tumor cell survival and proliferation. Leukemia 2010; 24: 1025-36.
38. Perez-Galan P, Dreyling M, Wiestner A,. Mantle cell lymphoma: biology, pathogenesis, and the molecular basis of treatment in the genomic era. Blood 2011; 117: 26-38.
39. Hegde GV, Nordgren TM, Munger CM, et al. Novel therapy for therapy-resistant mantle cell lymphoma: multipronged approach with targeting of hedgehog signaling. Int J Cancer 2012; 131: 2951-60.
40. Hegde GV, Munger CM, Emanuel K, et al. Targeting of sonic hedgehog-GLI signaling: a potential strategy to improve therapy for mantle cell lymphoma. Mol. Cancer Ther 2008; 7: 1450-60.
41. Peacock CD, Wang Q, Gesell GS, et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma. Proc Natl Acad Sci U S A 2007; 104: 4048-53.
42. Blotta S, Jakubikova J, Calimeri T, et al. Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma. Blood 2012; 120: 5002-13.
43. Clement V, Sanchez P, de Tribolet N, et al. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol:CB 2007; 17: 165-72.
44. Reardon DA, Perry JR, Brandes AA, et al. Advances in malignant glioma drug discovery. Expert Opin Drug Discov 2011; 6: 739-53.
45. Low JA, de Sauvage FJ,. Clinical experience with Hedgehog pathway inhibitors. J Clin Oncol 2010; 28: 5321-6.
46. Heller E, Hurchla MA, Xiang J, et al. Hedgehog signaling inhibition blocks growth of resistant tumors through effects on tumor microenvironment. Cancer Res 2012; 72: 897-907.
47. Mas C, Ruiz i Altaba A,. Small molecule modulation of HH-GLI signaling: current leads, trials and tribulations. Biochem Pharmacol 2010; 80: 712-23.
48. McMillan R, Matsui W,. Molecular pathways: the hedgehog signaling pathway in cancer. Clin Cancer Res 2012; 18: 4883-8.
49. Atwood SX, Chang AL, Oro AE,. Hedgehog pathway inhibition and the race against tumor evolution. J Cell Biol 2012; 199: 193-7.
50. Bosanac I, Maun HR, Scales SJ, et al. The structure of SHH in complex with HHIP reveals a recognition role for the Shh pseudo active site in signaling. Nat Struct Mol Biol 2009; 16: 691-7.
51. Stanton BZ, Peng LF, Maloof N, et al. A small molecule that binds Hedgehog and blocks its signaling in human cells. Nat Chem Biol 2009; 5: 154-6.
52. Peng LF, Stanton BZ, Maloof N, et al. Syntheses of aminoalcohol-derived macrocycles leading to a small-molecule binder to and inhibitor of Sonic Hedgehog. Bioorg Med Chem Lett 2009; 19: 6319-25.
53. Hyman JM, Firestone AJ, Heine VM, et al. Small-molecule inhibitors reveal multiple strategies for Hedgehog pathway blockade. Proc Natl Acad Sci U S A 2009; 106: 14132-7.
54. Peukert S, Miller-Moslin K,. Small-molecule inhibitors of the hedgehog signaling pathway as cancer therapeutics. ChemMedChem 2010; 5: 500-12.
55. Hassounah NB, Bunch TA, McDermott KM,. Molecular pathways: the role of primary cilia in cancer progression and therapeutics with a focus on Hedgehog signaling. Clin Cancer Res 2012; 18: 2429-35.
56. Yang L, Xie G, Fan Q, Xie J,. Activation of the hedgehog-signaling pathway in human cancer and the clinical implications. Oncogene 2010; 29: 469-81.
57. Schnidar H, Eberl M, Klingler S, et al. Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway. Cancer Res 2009; 69: 1284-92.
58. Dennler S, Andre J, Alexaki I, et al. Induction of sonic hedgehog mediators by transforming growth factor-beta: Smad3-dependent activation of Gli2 and Gli1 expression in vitro and in vivo. Cancer Res 2007; 67: 6981-6.
59. Johnson RW, Nguyen MP, Padalecki SS, et al. TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling. Cancer Res 2011; 71: 822-31.
60. Fingas CD, Bronk SF, Werneburg NW, et al. Myofibroblast-derived PDGF-BB promotes Hedgehog survival signaling in cholangiocarcinoma cells. Hepatology 2011; 54: 2076-88.
61. Das S, Samant RS, Shevde LA,. Non-classical activation of Hedgehog signaling enhances multidrug resistance and makes cancer cells refractory to SMOH-targeting Hedgehog inhibition. J Biol Chem 2013; 288: 11824-33.
62. Atwood SX, Li M, Lee A, et al. GLI activation by atypical protein kinase C iota/lambda regulates the growth of basal cell carcinomas. Nature 2013; 494: 484-8.
63. Ruiz i Altaba A,. Therapeutic inhibition of Hedgehog-GLI signaling in cancer: epithelial, stromal, or stem cell targets? Cancer cell 2008; 14: 281-3.
64. Merchant AA, Matsui W,. Targeting Hedgehog- A cancer stem cell pathway. Clin Cancer Res 2010; 16: 3130-40.